Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1982 1
1988 2
1989 1
1990 2
1993 4
1994 9
1995 7
1996 7
1997 13
1998 13
1999 22
2000 35
2001 31
2002 22
2003 25
2004 38
2005 49
2006 63
2007 57
2008 66
2009 92
2010 122
2011 146
2012 196
2013 182
2014 219
2015 205
2016 196
2017 214
2018 193
2019 217
2020 247
2021 169
Text availability
Article attribute
Article type
Publication date

Search Results

2,562 results
Results by year
Filters applied: . Clear all
Page 1
Brigatinib Versus Crizotinib in Advanced ALK Inhibitor-Naive ALK-Positive Non-Small Cell Lung Cancer: Second Interim Analysis of the Phase III ALTA-1L Trial.
Camidge DR, Kim HR, Ahn MJ, Yang JCH, Han JY, Hochmair MJ, Lee KH, Delmonte A, García Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira A, Gettinger SN, Tiseo M, Lin HM, Gupta N, Hanley MJ, Ni Q, Zhang P, Popat S. Camidge DR, et al. Among authors: kim hr. J Clin Oncol. 2020 Nov 1;38(31):3592-3603. doi: 10.1200/JCO.20.00505. Epub 2020 Aug 11. J Clin Oncol. 2020. PMID: 32780660 Clinical Trial.
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
Rudin CM, Awad MM, Navarro A, Gottfried M, Peters S, Csőszi T, Cheema PK, Rodriguez-Abreu D, Wollner M, Yang JC, Mazieres J, Orlandi FJ, Luft A, Gümüş M, Kato T, Kalemkerian GP, Luo Y, Ebiana V, Pietanza MC, Kim HR; KEYNOTE-604 Investigators. Rudin CM, et al. Among authors: kim hr. J Clin Oncol. 2020 Jul 20;38(21):2369-2379. doi: 10.1200/JCO.20.00793. Epub 2020 May 29. J Clin Oncol. 2020. PMID: 32468956 Free PMC article. Clinical Trial.
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Yun J, Lee SH, Kim SY, Jeong SY, Kim JH, Pyo KH, Park CW, Heo SG, Yun MR, Lim S, Lim SM, Hong MH, Kim HR, Thayu M, Curtin JC, Knoblauch RE, Lorenzi MV, Roshak A, Cho BC. Yun J, et al. Among authors: kim hr. Cancer Discov. 2020 Aug;10(8):1194-1209. doi: 10.1158/2159-8290.CD-20-0116. Epub 2020 May 15. Cancer Discov. 2020. PMID: 32414908 Free article.
Assembly of a GPCR-G Protein Complex.
Du Y, Duc NM, Rasmussen SGF, Hilger D, Kubiak X, Wang L, Bohon J, Kim HR, Wegrecki M, Asuru A, Jeong KM, Lee J, Chance MR, Lodowski DT, Kobilka BK, Chung KY. Du Y, et al. Among authors: kim hr. Cell. 2019 May 16;177(5):1232-1242.e11. doi: 10.1016/j.cell.2019.04.022. Epub 2019 May 9. Cell. 2019. PMID: 31080064 Free PMC article.
A Unified Framework for Dopamine Signals across Timescales.
Kim HR, Malik AN, Mikhael JG, Bech P, Tsutsui-Kimura I, Sun F, Zhang Y, Li Y, Watabe-Uchida M, Gershman SJ, Uchida N. Kim HR, et al. Cell. 2020 Dec 10;183(6):1600-1616.e25. doi: 10.1016/j.cell.2020.11.013. Epub 2020 Nov 27. Cell. 2020. PMID: 33248024
Acute Kidney Injury and Kidney Damage in COVID-19 Patients.
Na KR, Kim HR, Ham Y, Choi DE, Lee KW, Moon JY, Kim YS, Cheon S, Sohn KM, Kim J, Kim S, Jeong H, Jeon JW. Na KR, et al. Among authors: kim hr. J Korean Med Sci. 2020 Jul 20;35(28):e257. doi: 10.3346/jkms.2020.35.e257. J Korean Med Sci. 2020. PMID: 32686373 Free PMC article.
One-step generation of modular CAR-T cells with AAV-Cpf1.
Dai X, Park JJ, Du Y, Kim HR, Wang G, Errami Y, Chen S. Dai X, et al. Among authors: kim hr. Nat Methods. 2019 Mar;16(3):247-254. doi: 10.1038/s41592-019-0329-7. Epub 2019 Feb 25. Nat Methods. 2019. PMID: 30804551 Free PMC article.
2,562 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page